Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Tsuchiya

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
International Journal of Molecular Sciences|February 11, 2023
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron MetabolismChie Ogawa, Ken Tsuchiya, Kunimi Maeda
Contributions to Nephrology|May 28, 2019
Malnutrition-Wasting Conditions in Older Dialysis Patients: An Individualized ApproachNorio Hanafusa, Ken Tsuchiya, Kosaku Nitta
Nihon Jinzo Gakkai Shi|March 5, 2011
[Prevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality]Yuya Nakamura, Ken Tsuchiya, Kosaku Nitta, et al.
Plos One|June 18, 2021
Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfaChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Blood Purification|December 15, 2015
Differences in the Characteristics of Dialysis Patients in Japan Compared with Those in Other CountriesNaoki Kimata, Ken Tsuchiya, Takashi Akiba, et al.
Annals of Hematology|December 4, 2014
Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphomaMasaki Hara, Minoru Ando, Ken Tsuchiya, et al.
World Journal of Diabetes|February 17, 2015
Transcriptional factors, Mafs and their biological rolesMariko Tsuchiya, Ryoichi Misaka, Kosaku Nitta, et al.
International Journal of Molecular Sciences|October 1, 2020
A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis PatientsChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Nutrients|January 8, 2023
Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational StudyChie Ogawa, Ken Tsuchiya, Mineko Kanemitsu, et al.
Contributions to Nephrology|July 25, 2018
Intermittent Infusion Hemodiafiltration: The Principle and Its Clinical ApplicationKei Eguchi, Michio Mineshima, Daigo Kamei, et al.
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
International Journal of Molecular Sciences|February 11, 2023
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron MetabolismChie Ogawa, Ken Tsuchiya, Kunimi Maeda
Contributions to Nephrology|May 28, 2019
Malnutrition-Wasting Conditions in Older Dialysis Patients: An Individualized ApproachNorio Hanafusa, Ken Tsuchiya, Kosaku Nitta
Nihon Jinzo Gakkai Shi|March 5, 2011
[Prevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality]Yuya Nakamura, Ken Tsuchiya, Kosaku Nitta, et al.
Plos One|June 18, 2021
Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfaChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Blood Purification|December 15, 2015
Differences in the Characteristics of Dialysis Patients in Japan Compared with Those in Other CountriesNaoki Kimata, Ken Tsuchiya, Takashi Akiba, et al.
Annals of Hematology|December 4, 2014
Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphomaMasaki Hara, Minoru Ando, Ken Tsuchiya, et al.
World Journal of Diabetes|February 17, 2015
Transcriptional factors, Mafs and their biological rolesMariko Tsuchiya, Ryoichi Misaka, Kosaku Nitta, et al.
International Journal of Molecular Sciences|October 1, 2020
A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis PatientsChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Nutrients|January 8, 2023
Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational StudyChie Ogawa, Ken Tsuchiya, Mineko Kanemitsu, et al.
Contributions to Nephrology|July 25, 2018
Intermittent Infusion Hemodiafiltration: The Principle and Its Clinical ApplicationKei Eguchi, Michio Mineshima, Daigo Kamei, et al.
Pageof 24